BCY17901 TFA is a potent irreversible transferrin receptor 1 (TfR1) inhibitor (Ki=12 nM). BCY17901 TFA inhibits TfR1-mediated endocytosis and iron transport, and suppresses the proliferation of tumor cells dependent on iron metabolism. BCY17901 TFA can be used in the research of solid tumors (such as breast cancer, glioblastoma) and neurodegenerative diseases[1].
Molecular Weight:
2236.46 (free base)
Purity:
99.80
Formula:
C99H134N24O30S3.xC2HF3O2
Target:
Transferrin Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
